Rare diseases
Investigational molecules
Locations
Back to Germany840 clinical trials in Oldenburg In Holstein, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Early Sedation with Dexmedetomidine vs. Placebo for Older Critically Ill Patients on Ventilators
GermanyStudy on Zanubrutinib, Tislelizumab, and Sonrotoclax for Patients with Richter Transformation (a type of lymphoma)
GermanyStudy of Venetoclax, Ibrutinib, and Rituximab or Bendamustine Combination for Patients with Untreated Mantle Cell Lymphoma Not Suitable for High-Dose Therapy
GermanyStudy on Venetoclax and Obinutuzumab for Adults with Recurring Chronic Lymphocytic Leukemia
GermanyStudy on Advanced Laryngeal and Hypopharyngeal Cancer: Comparing Docetaxel, Cisplatin, and Pembrolizumab for Patients Eligible for Laryngectomy
GermanyStudy on the Safety of Long-Term Use of Deucrictibant for Treating Hereditary Angioedema Attacks in Patients with C1-Inhibitor Deficiency
GermanyStudy on CAR-T-cell Therapy with Rituximab and Ibrutinib for Patients with High-Risk Mantle Cell Lymphoma
GermanyStudy on the Effectiveness and Safety of Lifileucel and Pembrolizumab for Patients with Untreated, Unresectable, or Metastatic Melanoma
GermanyStudy on Long-Term Safety and Efficacy of Litifilimab for Adults with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy
GermanyStudy on Venetoclax and Drug Combination for Adults with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with Excess Blasts-2
GermanyStudy on Venetoclax and Epcoritamab for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
GermanyStudy on Long-term Safety and Efficacy of Efgartigimod PH20 SC in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on Type 2 Diabetes management and treatments, including studies of novel weekly insulin alternatives and oral medications for glycemic control.
Multiple studies evaluating new therapeutic approaches for better diabetes management and reducing cardiovascular risks.
Comprehensive research into obesity treatment and weight-related conditions, examining new therapeutic combinations and their effects on weight loss and associated health conditions.
Studies focusing on innovative approaches to weight management and treating obesity-related health complications.
Research examining treatments for atherosclerotic cardiovascular disease and related conditions, with emphasis on preventing major adverse cardiovascular events.
Trials evaluating new medications for improving cardiovascular outcomes in high-risk patients.
Clinical investigations of treatments for Crohn's Disease and other digestive conditions, focusing on long-term efficacy and safety of new therapeutic approaches.
Studies aimed at improving quality of life for patients with chronic gastrointestinal conditions.
Advanced studies in colorectal cancer treatment and management, including innovative approaches to Stage II and III cancer therapy.
Trials evaluating new treatment strategies for improving outcomes in cancer patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
